PYC THERAPEUTICS LIMITED - Announcements

0.75%

$1.35

Market Cap $787.4M

Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

PYC	Trading Halt	PRICE SENSITIVE	23/03/11	24.62KB	Share
PYC	Phylogica Discovery Spin-Off with University of Cambridge	PRICE SENSITIVE	09/03/11	97.85KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/11	242.56KB	Share
PYC	Phylogica - Isogenica Technology Collaboration	PRICE SENSITIVE	23/02/11	35.65KB	Share
PYC	Phylogica - New Potential For Treating Brain Injury	PRICE SENSITIVE	21/02/11	102.21KB	Share
PYC	Phylogica Announces Successful Collaboration with Roche	PRICE SENSITIVE	17/02/11	83.75KB	Share
PYC	FNN interview N Woolf Pfizer Deal, Goals for 2011	PRICE SENSITIVE	17/02/11	147.27KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	59.65KB	Share
PYC	Phylogica Accesses Novel Half-Life Extension Technology	PRICE SENSITIVE	13/01/11	31.68KB	Share
PYC	Phylogica Signs Collaboration and Licensing Deal with Pfizer	PRICE SENSITIVE	20/12/10	86.62KB	Share
PYC	Interview Nick Woolf CFO and VP Corp Development	PRICE SENSITIVE	16/12/10	96.12KB	Share
PYC	MedImmune drug discovery activities commence	PRICE SENSITIVE	02/11/10	24.48KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/10	56.92KB	Share
PYC	PHYLOGICA AND ROCHE COMPLETE FIRST STAGE OF PARTNERSHIP	PRICE SENSITIVE	21/10/10	79.1KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	31/08/10	74.77KB	Share
PYC	Renounceable Issue Prospectus	PRICE SENSITIVE	30/08/10	285.72KB	Share
PYC	Fully Underwritten Renouncable Rights Issue	PRICE SENSITIVE	26/08/10	22.18KB	Share
PYC	Trading Halt	PRICE SENSITIVE	23/08/10	27.12KB	Share
PYC	Phylogica Signs Agreement with MedImmune / AstraZeneca	PRICE SENSITIVE	18/08/10	85.77KB	Share
PYC	Reinstatement to Official Quotation	PRICE SENSITIVE	18/08/10	7.8KB	Share
PYC	Suspension from Official Quotation	PRICE SENSITIVE	05/08/10	20.33KB	Share
PYC	Trading Halt	PRICE SENSITIVE	03/08/10	24.62KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	38.96KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/10	40.87KB	Share
PYC	New Patent Allowance	PRICE SENSITIVE	02/03/10	33.33KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/10	452.39KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/10	39.14KB	Share
PYC	Agreement with Major UK company to Build New Drugs	PRICE SENSITIVE	18/01/10	38.72KB	Share
PYC	Phylogica Signs Agreement with Roche	PRICE SENSITIVE	18/12/09	123.76KB	Share
PYC	Trading Halt	PRICE SENSITIVE	17/12/09	24.35KB	Share
PYC	Reinstatement to official quotation	PRICE SENSITIVE	08/12/09	29.49KB	Share
PYC	Completion of fund raising and partnership negotiation	PRICE SENSITIVE	08/12/09	28.37KB	Share
PYC	Suspension from Official Quotation	PRICE SENSITIVE	03/12/09	31.02KB	Share
PYC	Trading Halt	PRICE SENSITIVE	02/12/09	9.99KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	39.01KB	Share
PYC	Response to ASX Price and Volume Query	PRICE SENSITIVE	10/09/09	113.17KB	Share
PYC	Preliminary Final Report	PRICE SENSITIVE	31/08/09	67.7KB	Share
PYC	Advanced Negotiations	PRICE SENSITIVE	26/08/09	26.7KB	Share
PYC	New Patent allowed for Phylogica's anti-inflammatory peptide	PRICE SENSITIVE	03/08/09	28.22KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/09	39.95KB	Share
PYC	Pro-forma Cash Position 31 March 2009	PRICE SENSITIVE	05/05/09	81.63KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/09	67.28KB	Share
PYC	Drug Delivery Collaboration	PRICE SENSITIVE	14/04/09	42.77KB	Share
PYC	Collaboration with the MRC Hutchison Institute a success	PRICE SENSITIVE	04/03/09	44.72KB	Share
PYC	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/09	2.29MB	Share
BTC +PYC	Capital Raising Programme	PRICE SENSITIVE	26/02/09	62.08KB	Share
PYC	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	67.64KB	Share
PYC	Company Update	PRICE SENSITIVE	22/12/08	66.28KB	Share
PYC	Phylogica aquires all shares in associate	PRICE SENSITIVE	24/11/08	68.16KB	Share

PYCTrading Halt
23/03/11	PRICE SENSITIVE	24.62KB	Share
PYCPhylogica Discovery Spin-Off with University of Cambridge
09/03/11	PRICE SENSITIVE	97.85KB	Share
PYCHalf Yearly Report and Accounts
24/02/11	PRICE SENSITIVE	242.56KB	Share
PYCPhylogica - Isogenica Technology Collaboration
23/02/11	PRICE SENSITIVE	35.65KB	Share
PYCPhylogica - New Potential For Treating Brain Injury
21/02/11	PRICE SENSITIVE	102.21KB	Share
PYCPhylogica Announces Successful Collaboration with Roche
17/02/11	PRICE SENSITIVE	83.75KB	Share
PYCFNN interview N Woolf Pfizer Deal, Goals for 2011
17/02/11	PRICE SENSITIVE	147.27KB	Share
PYCAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	59.65KB	Share
PYCPhylogica Accesses Novel Half-Life Extension Technology
13/01/11	PRICE SENSITIVE	31.68KB	Share
PYCPhylogica Signs Collaboration and Licensing Deal with Pfizer
20/12/10	PRICE SENSITIVE	86.62KB	Share
PYCInterview Nick Woolf CFO and VP Corp Development
16/12/10	PRICE SENSITIVE	96.12KB	Share
PYCMedImmune drug discovery activities commence
02/11/10	PRICE SENSITIVE	24.48KB	Share
PYCAppendix 4C - quarterly
29/10/10	PRICE SENSITIVE	56.92KB	Share
PYCPHYLOGICA AND ROCHE COMPLETE FIRST STAGE OF PARTNERSHIP
21/10/10	PRICE SENSITIVE	79.1KB	Share
PYCPreliminary Final Report
31/08/10	PRICE SENSITIVE	74.77KB	Share
PYCRenounceable Issue Prospectus
30/08/10	PRICE SENSITIVE	285.72KB	Share
PYCFully Underwritten Renouncable Rights Issue
26/08/10	PRICE SENSITIVE	22.18KB	Share
PYCTrading Halt
23/08/10	PRICE SENSITIVE	27.12KB	Share
PYCPhylogica Signs Agreement with MedImmune / AstraZeneca
18/08/10	PRICE SENSITIVE	85.77KB	Share
PYCReinstatement to Official Quotation
18/08/10	PRICE SENSITIVE	7.8KB	Share
PYCSuspension from Official Quotation
05/08/10	PRICE SENSITIVE	20.33KB	Share
PYCTrading Halt
03/08/10	PRICE SENSITIVE	24.62KB	Share
PYCAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	38.96KB	Share
PYCAppendix 4C - quarterly
30/04/10	PRICE SENSITIVE	40.87KB	Share
PYCNew Patent Allowance
02/03/10	PRICE SENSITIVE	33.33KB	Share
PYCHalf Yearly Report and Accounts
24/02/10	PRICE SENSITIVE	452.39KB	Share
PYCAppendix 4C - quarterly
29/01/10	PRICE SENSITIVE	39.14KB	Share
PYCAgreement with Major UK company to Build New Drugs
18/01/10	PRICE SENSITIVE	38.72KB	Share
PYCPhylogica Signs Agreement with Roche
18/12/09	PRICE SENSITIVE	123.76KB	Share
PYCTrading Halt
17/12/09	PRICE SENSITIVE	24.35KB	Share
PYCReinstatement to official quotation
08/12/09	PRICE SENSITIVE	29.49KB	Share
PYCCompletion of fund raising and partnership negotiation
08/12/09	PRICE SENSITIVE	28.37KB	Share
PYCSuspension from Official Quotation
03/12/09	PRICE SENSITIVE	31.02KB	Share
PYCTrading Halt
02/12/09	PRICE SENSITIVE	9.99KB	Share
PYCAppendix 4C - quarterly
30/10/09	PRICE SENSITIVE	39.01KB	Share
PYCResponse to ASX Price and Volume Query
10/09/09	PRICE SENSITIVE	113.17KB	Share
PYCPreliminary Final Report
31/08/09	PRICE SENSITIVE	67.7KB	Share
PYCAdvanced Negotiations
26/08/09	PRICE SENSITIVE	26.7KB	Share
PYCNew Patent allowed for Phylogica's anti-inflammatory peptide
03/08/09	PRICE SENSITIVE	28.22KB	Share
PYCAppendix 4C - quarterly
29/07/09	PRICE SENSITIVE	39.95KB	Share
PYCPro-forma Cash Position 31 March 2009
05/05/09	PRICE SENSITIVE	81.63KB	Share
PYCAppendix 4C - quarterly
30/04/09	PRICE SENSITIVE	67.28KB	Share
PYCDrug Delivery Collaboration
14/04/09	PRICE SENSITIVE	42.77KB	Share
PYCCollaboration with the MRC Hutchison Institute a success
04/03/09	PRICE SENSITIVE	44.72KB	Share
PYCHalf Yearly Report and Accounts
27/02/09	PRICE SENSITIVE	2.29MB	Share
BTC +PYCCapital Raising Programme
26/02/09	PRICE SENSITIVE	62.08KB	Share
PYCAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	67.64KB	Share
PYCCompany Update
22/12/08	PRICE SENSITIVE	66.28KB	Share
PYCPhylogica aquires all shares in associate
24/11/08	PRICE SENSITIVE	68.16KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.35		Change 0.010(0.75%)		Mkt cap ! $787.4M

Open	High	Low	Value	Volume
$1.34	$1.36	$1.32	$249.8K	186.1K

Buyers (Bids)

No.	Vol.	Price($)
1	550	$1.34

Sellers (Offers)

Price($)	Vol.	No.
$1.35	2383	3

View Market Depth

No.	Vol.	Price($)
1	550	1.335
1	15000	1.330
1	391	1.315
1	25000	1.310
1	391	1.305

Price($)	Vol.	No.
1.350	2383	3
1.360	7886	2
1.365	2198	1
1.370	10391	2
1.380	391	1

Last trade - 12.11pm 13/08/2025 (20 minute delay)


Last $1.35		Change 0.010 ( 0.37 %)
Open	High	Low	Volume
$1.34	$1.36	$1.33	25486
Last updated 12.19pm 13/08/2025 ?

PYC (ASX) Chart

PYC THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories